Clinical Laserthermia Systems AB (publ) (CLS-B.ST)

SEK 3.36

(-7.69%)

Long Term Debt Summary of Clinical Laserthermia Systems AB (publ)

  • Clinical Laserthermia Systems AB (publ)'s latest annual long term debt in 2023 was 223 Thousand SEK , down 0.0% from previous year.
  • Clinical Laserthermia Systems AB (publ)'s latest quarterly long term debt in 2024 Q3 was - SEK , down 0.0% from previous quarter.
  • Clinical Laserthermia Systems AB (publ) reported annual long term debt of - SEK in 2022, down -100.0% from previous year.
  • Clinical Laserthermia Systems AB (publ) reported annual long term debt of 100 Thousand SEK in 2021, down -50.0% from previous year.
  • Clinical Laserthermia Systems AB (publ) reported quarterly long term debt of - SEK for 2024 Q3, down 0.0% from previous quarter.
  • Clinical Laserthermia Systems AB (publ) reported quarterly long term debt of 223 Thousand SEK for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Clinical Laserthermia Systems AB (publ) (2023 - 2008)

Historical Annual Long Term Debt of Clinical Laserthermia Systems AB (publ) (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 223 Thousand SEK 0.0%
2022 - SEK -100.0%
2021 100 Thousand SEK -50.0%
2020 200 Thousand SEK -66.67%
2019 600 Thousand SEK -40.0%
2018 1 Million SEK -28.57%
2017 1.4 Million SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK -100.0%
2012 73.5 Thousand SEK -49.94%
2011 146.83 Thousand SEK 0.0%
2010 - SEK 0.0%
2009 - SEK 0.0%
2008 - SEK 0.0%

Peer Long Term Debt Comparison of Clinical Laserthermia Systems AB (publ)

Name Long Term Debt Long Term Debt Difference
Acarix AB (publ) - SEK -Infinity%
ADDvise Group AB (publ) 1.45 Billion SEK 99.985%
ADDvise Group AB (publ) 1.45 Billion SEK 99.985%
Arcoma AB 1.92 Million SEK 88.428%
Bactiguard Holding AB (publ) 42.3 Million SEK 99.473%
BICO Group AB (publ) 1.75 Billion SEK 99.987%
Boule Diagnostics AB (publ) 57.7 Million SEK 99.614%
CellaVision AB (publ) 28.66 Million SEK 99.222%
Chordate Medical Holding AB (publ) - SEK -Infinity%
C-Rad AB (publ) 1.75 Million SEK 87.279%
Duearity AB (publ) 2.94 Million SEK 92.415%
Dignitana AB (publ) 6.07 Million SEK 96.33%
Episurf Medical AB (publ) 2.3 Million SEK 90.304%
Getinge AB (publ) 3.9 Billion SEK 99.994%
Scandinavian Real Heart AB (Publ) 6.35 Million SEK 96.49%
Iconovo AB (publ) 4.9 Million SEK 95.455%
Integrum AB (publ) 4.84 Million SEK 95.397%
Luxbright AB (publ) 206.02 Thousand SEK -8.24%
Mentice AB (publ) 2.14 Million SEK 89.599%
OssDsign AB (publ) 214 Thousand SEK -4.206%
Paxman AB (publ) 2.53 Million SEK 91.193%
Promimic AB (publ) - SEK -Infinity%
Qlife Holding AB (publ) 3 Million SEK 92.577%
SciBase Holding AB (publ) 4.17 Million SEK 94.664%
ScandiDos AB (publ) - SEK -Infinity%
Sectra AB (publ) 19.2 Million SEK 98.839%
Sedana Medical AB (publ) 1.01 Million SEK 77.964%
Senzime AB (publ) 8.57 Million SEK 97.4%
SpectraCure AB (publ) 4.39 Million SEK 94.928%
Stille AB 38.06 Million SEK 99.414%
Vitrolife AB (publ) 1.87 Billion SEK 99.988%
Xvivo Perfusion AB (publ) 21.16 Million SEK 98.947%